Australia Stocks snap seven-day rally as investors opt for profit

Image
Capital Market
Last Updated : Dec 10 2020 | 5:04 PM IST
The Australian shares declined on Thursday, 10 December 2020, with benchmark indices snapping seven straight sessions of winning streak, as investors opted to secure recent gains after the market's recent rise, with geopolitical tensions with China, concerns over a long-awaited U.S. stimulus package, and eyes on upcoming events in Europe adding to a risk-off mood.

At closing bell, the benchmark S&P/ASX200 dropped 45.35 points, or 0.67%, to 6,683.12. The broader All Ordinaries fell 48.25 points, or 0.69%, to 6,917.14.

The market was ripe for taking profits following a weak lead from Wall Street overnight after disappointment over the halting progress of economic US stimulus talks. Meanwhile, concerns over stalled talks in the United States on its delayed stimulus package to address the economic fallout from the coronavirus pandemic, which has battered the U.S. economy, also saw investors taking profits.

Tensions between Australia and China escalated further after Beijing said it would temporarily impose anti-subsidy fees on some Australian wine imports from Dec. 11.

Investors were also closely eyeing a number of upcoming events in Europe, including UK-EU trade talks, with British Prime Minister Boris Johnson and the European Union's chief executive agreeing to conclude talks on a new trade pact by the end of the week, and the European Central Bank's policy meeting.

Today, losses were widespread with every sector lower. Leading the falls were the healthcare, IT and communications sectors which all fell roughly 1% or more. The financials and utilities outperformed, experiencing narrower declines.

Gold stocks fell the most, following a steep sell-off in bullion prices on Wednesday, as a breakthrough in U.S. fiscal stimulus negotiations remained elusive.

Shares of travel-related firms such as Qantas Airways and Sydney Airport Holdings declined after UK and U.S. health regulators issued allergy warning on Pfizer's COVID-19 vaccine.

Appen (APX) fell sharply with the AI firm sliding 12.4% on a trading update. APX downgraded its FY20 guidance on weaker than expected revenue in Q4 due to COVID-19 lockdowns in California, impacting its major customers. FY underlying EBITDA is now expected between $106-109 million from $125-130 million.

CURRENCY NEWS: The Aussie dollar remains well supported by strong commodity prices, particularly iron ore, and holds at 74.66 US cents.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 10 2020 | 4:47 PM IST

Next Story